TBPH Buybacks
5 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–5; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Theravance Biopharma, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |
| Theravance Biopharma, Inc. | 2024-03-31 | Reported repurchase cash | $445,000.00 |
| Theravance Biopharma, Inc. | 2023-12-31 | Reported repurchase cash | $30.26M |
| Theravance Biopharma, Inc. | 2023-03-31 | Reported repurchase cash | $55.35M |
| Theravance Biopharma, Inc. | 2022-12-31 | Reported repurchase cash | $34.79M |